Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone.
about
Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.Nanotechnology-enabled delivery of NQO1 bioactivatable drugs.Recent updates in utilizing prodrugs in drug delivery (2013-2015).Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer ActivityEnhancing Oral Absorption of β-Lapachone: Progress Till Date.
P2860
Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@ast
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@en
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@nl
type
label
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@ast
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@en
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@nl
prefLabel
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@ast
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@en
Prodrug strategy to achieve ly ...... er derivatives of β-Lapachone.
@nl
P2093
P2860
P356
P1476
Prodrug strategy to achieve ly ...... ter derivatives of β-Lapachone
@en
P2093
David A Boothman
Gang Huang
Jinming Gao
Longshan Li
Xinpeng Ma
Xiumei Huang
Xiuquan Luo
P2860
P304
P356
10.1002/ADHM.201300590
P50
P577
2014-02-14T00:00:00Z